Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Autoimmunity Highlights
Published in: Autoimmunity Highlights 1/2018

Open Access 01-12-2018 | Letter to the Editor

Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome

Authors: Paul R. J. Ames, Luis L. Lopez, Mira Merashli, Eiji Matsuura

Published in: Autoimmunity Highlights | Issue 1/2018

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Fabris M, Cifù A, Pistis C, Siega-Ducaton M, Fontana DE, Giacomello R, Tonutti E, Curcio F (2017) Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies. Auto Immun Highlights 8:5CrossRef
2.
Kobayashi K, Kishi M, Atsumi T et al (2003) Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. J Lipid Res 44:716–726CrossRef
3.
Liu Q, Kobayashi K, Furukawa J et al (2002) Omega-carboxyl variants of 7 ketocholesteryl esters are ligands for beta-(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages. J Lipid Res 43:1486–1495CrossRef
4.
Tselepis AD, Karabina SA, Stengel D, Piedagnel R, Chapman MJ, Ninio E (2001) N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL. J Lipid Res 42:1645–1654PubMed
5.
Ames PRJ, Nourooz-Zadeh J, Tommasino C, Alves J, Brancaccio V, Anggard EE (1998) Oxidative stress in primary antiphospholipid syndrome. Thromb Haemost 79:447–449CrossRef
6.
Ambrosio G, Oriente A, Napoli C et al (1994) Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet activating factor. J Clin Invest 93:2408–2416CrossRef
7.
Ames PRJ, Tommasino C, Alves J, Morrow JD, Iannaccone L, Fossati G, Caruso S, Caccavo F, Brancaccio V (2000) Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study. Lupus 9:688–695CrossRef
8.
Ames PR, Tommasino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V (1996) Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies–a crucial role for acquired free protein S deficiency. Thromb Haemost 76:190–194CrossRef
9.
Tsimikas S, Tsironis LD, Tselepis AD (2007) New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 27:2094–2099CrossRef
Metadata
Title
Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome
Authors
Paul R. J. Ames
Luis L. Lopez
Mira Merashli
Eiji Matsuura
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Autoimmunity Highlights / Issue 1/2018
Print ISSN: 2038-0305
Electronic ISSN: 2038-3274
DOI
https://doi.org/10.1007/s13317-018-0103-3

Other articles of this Issue 1/2018

Autoimmunity Highlights 1/2018 Go to the issue

Review Article

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Case Report

Rhabdomyolysis secondary to systemic lupus erythematosus

Original Article

Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease

Review Article

Remission of aggressive autoimmune disease (dermatomyositis) with removal of infective jaw pathology and ozone therapy: review and case report

Case Report

Isolated acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus in an 8-year-old girl

Original Article

Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits